Evidence map›Paper›PMID 35420394›Full record

ReviewProgress in biomaterials2022

Injectable hydrogels for bone and cartilage tissue engineering: a review.

Nafiseh Olov, Shadab Bagheri-Khoulenjani, Hamid Mirzadeh

Abstract readReview
In one paragraph

Review in Progress in biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Injectable Colloidal Hydrogels ofBiomacromolecules · 2023
    Article
  18. Injectable antibacterial Ag-HA/ GelMA hydrogel for bone tissue engineering.Frontiers in bioengineering and biotechnology · 2023
    Article
  19. Review
  20. Enhanced bone regeneration via local low-dose delivery of PTHFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nafiseh OlovPolymer and Colour Engineering Department, Amirkabir University of Technology, 424 Hafez-Ave., 15875-4413, Tehran, Iran.
Shadab Bagheri-KhoulenjaniPolymer and Colour Engineering Department, Amirkabir University of Technology, 424 Hafez-Ave., 15875-4413, Tehran, Iran. s.bagheri@aut.ac.ir.ORCID http://orcid.org/0000-0002-0478-0679
Hamid MirzadehPolymer and Colour Engineering Department, Amirkabir University of Technology, 424 Hafez-Ave., 15875-4413, Tehran, Iran. mirzadeh@aut.ac.ir.

Funding

National Institute for Medical Research Development 942955
6 · The paper itself

Abstract

Tissue engineering, using a combination of living cells, bioactive molecules, and three-dimensional porous scaffolds, is a promising alternative to traditional treatments such as the use of autografts and allografts for bone and cartilage tissue regeneration. Scaffolds, in this combination, can be applied either through surgery by implantation of cell-seeded pre-fabricated scaffolds, or through injection of a solidifying precursor and cell mixture, or as an injectable cell-seeded pre-fabricated scaffold. In situ forming and pre-fabricated injectable scaffolds can be injected directly into the defect site with complex shape and critical size in a minimally invasive manner. Proper and homogeneous distribution of cells, biological factors, and molecular signals in these injectable scaffolds is another advantage over pre-fabricated scaffolds. Due to the importance of injectable scaffolds in tissue engineering, here different types of injectable scaffolds, their design challenges, and applications in bone and cartilage tissue regeneration are reviewed.

Indexed as

Bone tissue engineeringCartilage tissue engineeringInjectable microparticlesInjectable shape memory scaffoldsIn situ injectable hydrogels

Identifiers

PMID35420394
PMCPMC9156638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.